| Identification | Back Directory | [Name]
TAK 21d | [CAS]
1143578-94-2 | [Synonyms]
TAK 21d
4-[4-(3,4-Difluorophenyl)-2-pyrimidinyl]-N-3-pyridazinyl-1-piperazinecarboxamide
1-Piperazinecarboxamide, 4-[4-(3,4-difluorophenyl)-2-pyrimidinyl]-N-3-pyridazinyl- | [Molecular Formula]
C19H17F2N7O | [MDL Number]
MFCD30182269 | [MOL File]
1143578-94-2.mol | [Molecular Weight]
397.38 |
| Hazard Information | Back Directory | [Uses]
TAK 21d is a fatty acid amide hydroloase (FAAH) inhibitor. | [in vivo]
FAAH-IN-6 (compound 21d) (1-10 mg/kg; p.o.) shows significantly ameliorates tactile allodynia in a dose-dependent fashion in SNI-induced neuropathic pain rats model[1].
FAAH-IN-6 (3-10 mg/kg; p.o.) shows significantly ameliorates tactile allodynia of the ipsilateral hind paw in CFA-induced inflammatory pain model[1]. | [storage]
Store at -20°C |
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|